ORIC Pharmaceuticals Inc (ORIC)
9.35
-0.13
(-1.37%)
USD |
NASDAQ |
Nov 05, 14:37
ORIC Pharmaceuticals Total Liabilities (Quarterly): 26.51M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 26.51M |
| March 31, 2024 | 22.14M |
| December 31, 2023 | 27.92M |
| September 30, 2023 | 26.92M |
| June 30, 2023 | 23.02M |
| March 31, 2023 | 23.84M |
| December 31, 2022 | 24.83M |
| September 30, 2022 | 23.18M |
| June 30, 2022 | 22.81M |
| March 31, 2022 | 21.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 25.67M |
| September 30, 2021 | 22.64M |
| June 30, 2021 | 9.904M |
| March 31, 2021 | 7.885M |
| December 31, 2020 | 9.221M |
| September 30, 2020 | 7.287M |
| June 30, 2020 | 6.278M |
| March 31, 2020 | 183.47M |
| December 31, 2019 | 184.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.278M
Minimum
Jun 2020
184.18M
Maximum
Dec 2019
36.83M
Average
23.02M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 328.91M |
| Shareholders Equity (Quarterly) | 302.40M |